Clinical Trial Update: Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008) [Phase 2]

View source ↗

Summary

A Phase 2 efficacy, tolerability and safety study in rheumatoid arthritis has completed, sponsored by Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED